시장보고서
상품코드
1193131

고양이울음증후군 치료 시장 : 치료법별(물리치료, 언어치료, 작업치료), 최종 사용자별(병원과 전문 클리닉, 기타) - 세계 기회 분석 및 산업 예측(2021-2031년)

Cri-du-chat Syndrome Treatment Market By Treatment (Physiotherapy, Speech therapy, Occupational therapy), By End User (Hospitals and specialty clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 148 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 고양이울음증후군 치료 시장은 2021년에 133만 2,460달러, 2031년에는 191만 8,210달러에 이르며, 2022년부터 2031년까지의 CAGR은 3.7%로 성장할 것으로 예측됩니다.

고양이울음증후군은 5p-증후군과 고양이 울림 증후군으로도 알려져 있으며, 5번 염색체의 짧은 팔(p팔)에서 유전 물질이 결실됨으로써 발생하는 드문 유전성 질환입니다. 이 비정상적인 염색체 결핍은 원인을 알 수 없습니다. 높은 목소리로 울고 머리가 작고 콧대가 평평하게 되어 있는 것이 고양이울음증후군 아기의 특징입니다.

약 5만명에 1명의 비율로 발병하고 있습니다고 합니다. 이 추정치는 감소 경향에 있습니다. 보다 정교하고 정기적인 유전자 검사가 이루어졌고, 많은 경증 사례가 발견되었기 때문에 25,000명 중 1명의 낮은 비율이 될 수 있습니다. 이와 같이, 크리듀샨 증후군의 높은 유병률과 유전성 질환의 진단의 증가가 시장의 성장을 뒷받침하고 있습니다.

이 증후군은 사용 가능한 특정 약리 치료법이 없습니다. 이 유전자 질환을 가진 어린이는 잠재력을 극대화하기 위해 부모, 치료사, 의료 및 교육 전문가로 구성된 팀의 지속적인 관리가 필요할 것입니다. 조기부터 일관된 물리치료, 작업치료, 언어치료을 실시함으로써, 아이들의 가능성을 최대한으로 이끌어 충실한 생활을 보낼 수 있습니다. 또한 물리치료, 작업치료, 언어치료에 대한 인지도와 장점의 증가가 시장을 견인하는 주요 요인이 되고 있습니다. 질병의 만연과 자기 부담의 증가로 건강 관리 비용이 크게 증가하고 있습니다. 이러한 요인은 시장 성장을 촉진하고 있습니다.

그러나 치료비의 높이가 시장 성장을 방해할 것으로 예상됩니다. 반대로 소비자의 요구를 충족시키는 신흥 시장의 성장 기회는 투자자들에게 큰 투자 기회가 될 것으로 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 개요

  • 시장의 정의와 범위
  • 주요 조사 결과
    • 주요 투자 포켓
  • Porter's Five Forces 분석
  • 주요 기업의 포지셔닝
  • 시장 역학
    • 촉진 요인
    • 억제 요인
    • 기회
  • COVID-19 영향 분석

제4장 고양이울음증후군 치료 시장 : 치료별

  • 개요
    • 시장 규모 및 예측
  • 물리치료
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 언어치료
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 작업치료
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별

제5장 고양이울음증후군 치료 시장 : 최종 사용자별

  • 개요
    • 시장 규모·예측
  • 병원 및 전문 클리닉
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별
  • 기타
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 점유율 분석 : 국가별

제6장 고양이울음증후군 치료제 시장 : 지역별

  • 개요
    • 시장 규모·예측
  • 북미
    • 주요 동향과 기회
    • 북미 시장 규모·예측 : 치료법별
    • 북미 시장 규모·예측 : 최종 사용자별
    • 북미 시장 규모·예측 : 국가별
      • 미국
      • 캐나다
      • 멕시코
  • 유럽
    • 주요 동향과 기회
    • 유럽의 시장 규모·예측 : 치료법별
    • 유럽 시장 규모·예측 : 최종 사용자별
    • 유럽 시장 규모·예측 : 국가별
      • 독일
      • 프랑스
      • 영국
      • 이탈리아
      • 스페인
      • 기타 유럽 지역
  • 아시아태평양
    • 주요 동향과 기회
    • 아시아태평양의 시장 규모·예측 : 치료법별
    • 아시아태평양의 시장 규모·예측 : 최종 사용자별
    • 아시아태평양의 시장 규모·예측 : 국가별
      • 일본
      • 중국
      • 인도
      • 호주
      • 한국
      • 기타 아시아태평양
  • LAMEA
    • 주요 동향과 기회
    • LAMEA의 시장 규모·예측 : 치료법별
    • LAMEA의 시장 규모·예측 : 엔드유저별
    • LAMEA의 시장 규모·예측 : 국가별
      • 브라질
      • 사우디아라비아
      • 남아프리카 공화국
      • 기타 LAMEA

제7장 기업 정세

  • 소개
  • 주요 성공 전략
  • 주요 10개사의 제품 매핑
  • 경쟁 대시보드
  • 경쟁 히트맵
  • 주요 발전

제8장 기업 프로필

  • Hoppers Physio
  • Jeevam Therapy
  • Physiocomestoyou
  • EURO-THERAPIES
  • Institute for Child Development
  • Blossoms Physiotherapy
  • Pediatric Advanced Therapy
  • Chatham Speech and Myo
  • Movement Masters Physical Therapy
  • Rio Children's Hospital
ksm 23.03.27

The global cri-du-chat syndrome treatment market was valued at $1,332.46 thousand in 2021, and is estimated to reach $1,918.21 thousand by 2031, growing at a CAGR of 3.7% from 2022 to 2031.

Cri du chat syndrome, also known as 5p- syndrome and cat cry syndrome, is a rare genetic disorder brought on by the deletion of genetic material from the short arm of chromosome 5 (the p arm), which is responsible for the illness. This unusual chromosomal loss has an unidentified cause. A high-pitched cry, a small head, and a flattened nasal bridge are the hallmarks of a baby with cri du chat syndrome.

It is estimated that one in every 50,000 or so infants has this disease. This estimate is decreasing. It may be as low as one in 25,000 with more sophisticated and regular genetic testing and many milder cases being detected. Thus, high prevalence of cri-du-chat syndrome along with increase in diagnosis for genetic diseases drives the market growth.

This syndrome has no particular pharmacological treatments available. To assist the child reach their full potential, children born with this genetic disorder will probably need ongoing care from a team made up of the parents, therapists, and medical and educational experts. They can achieve their full potential and lead fulfilling lives with early and consistent physical therapy, occupational and speech therapy. In addition, rise in awareness and advantages about physiotherapy, occupational & speech therapy is the major factor driving the market. The increase in prevalence of disease and out-of-pocket expenditure has led to a significant rise in healthcare cost. These factors propel the market growth.

However, high cost associated with therapy treatments are expected to hinder the growth of the market. Conversely, growth opportunities in emerging market to suffice the consumer demands is expected to provide a great opportunity for the investors to invest in the market.

The cri-du-chat syndrome treatment market is segmented on the basis of treatment, end user, and region. On the basis of product, the market is categorized into physiotherapy, speech therapy and occupation therapy. On the basis of end user, it is segmented into hospitals & specialty clinics and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).

The major players profiled in the report are Hoppers Physio, Jeevam Therapy, Physiocomestoyou, EURO-THERAPIES, Institute for Child Development, Blossoms Physiotherapy, Pediatric Advanced Therapy, Chatham Speech and Myo, Movement Masters Physical Therapy, and Rio Children's Hospital.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cri-du-chat syndrome treatment market analysis from 2021 to 2031 to identify the prevailing cri-du-chat syndrome treatment market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the cri-du-chat syndrome treatment market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global cri-du-chat syndrome treatment market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Treatment

  • Physiotherapy
  • Speech therapy
  • Occupational therapy

By End User

  • Hospitals and specialty clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Hoppers Physio
    • Chatham Speech and Myo
    • Movement Masters Physical Therapy
    • Rio Children's Hospital
    • Blossoms Physiotherapy
    • Institute for Child Development
    • Pediatric Advanced Therapy
    • EURO-THERAPIES
    • Physiocomestoyou
    • Jeevam Therapy

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Physiotherapy
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 Speech therapy
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country
  • 4.4 Occupational therapy
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market share analysis by country

CHAPTER 5: CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Hospitals and specialty clinics
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 Others
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country

CHAPTER 6: CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY REGION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 North America
    • 6.2.1 Key trends and opportunities
    • 6.2.2 North America Market size and forecast, by Treatment
    • 6.2.3 North America Market size and forecast, by End User
    • 6.2.4 North America Market size and forecast, by country
      • 6.2.4.1 U.S.
      • 6.2.4.1.1 Key market trends, growth factors and opportunities
      • 6.2.4.1.2 Market size and forecast, by Treatment
      • 6.2.4.1.3 Market size and forecast, by End User
      • 6.2.4.2 Canada
      • 6.2.4.2.1 Key market trends, growth factors and opportunities
      • 6.2.4.2.2 Market size and forecast, by Treatment
      • 6.2.4.2.3 Market size and forecast, by End User
      • 6.2.4.3 Mexico
      • 6.2.4.3.1 Key market trends, growth factors and opportunities
      • 6.2.4.3.2 Market size and forecast, by Treatment
      • 6.2.4.3.3 Market size and forecast, by End User
  • 6.3 Europe
    • 6.3.1 Key trends and opportunities
    • 6.3.2 Europe Market size and forecast, by Treatment
    • 6.3.3 Europe Market size and forecast, by End User
    • 6.3.4 Europe Market size and forecast, by country
      • 6.3.4.1 Germany
      • 6.3.4.1.1 Key market trends, growth factors and opportunities
      • 6.3.4.1.2 Market size and forecast, by Treatment
      • 6.3.4.1.3 Market size and forecast, by End User
      • 6.3.4.2 France
      • 6.3.4.2.1 Key market trends, growth factors and opportunities
      • 6.3.4.2.2 Market size and forecast, by Treatment
      • 6.3.4.2.3 Market size and forecast, by End User
      • 6.3.4.3 UK
      • 6.3.4.3.1 Key market trends, growth factors and opportunities
      • 6.3.4.3.2 Market size and forecast, by Treatment
      • 6.3.4.3.3 Market size and forecast, by End User
      • 6.3.4.4 Italy
      • 6.3.4.4.1 Key market trends, growth factors and opportunities
      • 6.3.4.4.2 Market size and forecast, by Treatment
      • 6.3.4.4.3 Market size and forecast, by End User
      • 6.3.4.5 Spain
      • 6.3.4.5.1 Key market trends, growth factors and opportunities
      • 6.3.4.5.2 Market size and forecast, by Treatment
      • 6.3.4.5.3 Market size and forecast, by End User
      • 6.3.4.6 Rest of Europe
      • 6.3.4.6.1 Key market trends, growth factors and opportunities
      • 6.3.4.6.2 Market size and forecast, by Treatment
      • 6.3.4.6.3 Market size and forecast, by End User
  • 6.4 Asia-Pacific
    • 6.4.1 Key trends and opportunities
    • 6.4.2 Asia-Pacific Market size and forecast, by Treatment
    • 6.4.3 Asia-Pacific Market size and forecast, by End User
    • 6.4.4 Asia-Pacific Market size and forecast, by country
      • 6.4.4.1 Japan
      • 6.4.4.1.1 Key market trends, growth factors and opportunities
      • 6.4.4.1.2 Market size and forecast, by Treatment
      • 6.4.4.1.3 Market size and forecast, by End User
      • 6.4.4.2 China
      • 6.4.4.2.1 Key market trends, growth factors and opportunities
      • 6.4.4.2.2 Market size and forecast, by Treatment
      • 6.4.4.2.3 Market size and forecast, by End User
      • 6.4.4.3 India
      • 6.4.4.3.1 Key market trends, growth factors and opportunities
      • 6.4.4.3.2 Market size and forecast, by Treatment
      • 6.4.4.3.3 Market size and forecast, by End User
      • 6.4.4.4 Australia
      • 6.4.4.4.1 Key market trends, growth factors and opportunities
      • 6.4.4.4.2 Market size and forecast, by Treatment
      • 6.4.4.4.3 Market size and forecast, by End User
      • 6.4.4.5 South Korea
      • 6.4.4.5.1 Key market trends, growth factors and opportunities
      • 6.4.4.5.2 Market size and forecast, by Treatment
      • 6.4.4.5.3 Market size and forecast, by End User
      • 6.4.4.6 Rest of Asia-Pacific
      • 6.4.4.6.1 Key market trends, growth factors and opportunities
      • 6.4.4.6.2 Market size and forecast, by Treatment
      • 6.4.4.6.3 Market size and forecast, by End User
  • 6.5 LAMEA
    • 6.5.1 Key trends and opportunities
    • 6.5.2 LAMEA Market size and forecast, by Treatment
    • 6.5.3 LAMEA Market size and forecast, by End User
    • 6.5.4 LAMEA Market size and forecast, by country
      • 6.5.4.1 Brazil
      • 6.5.4.1.1 Key market trends, growth factors and opportunities
      • 6.5.4.1.2 Market size and forecast, by Treatment
      • 6.5.4.1.3 Market size and forecast, by End User
      • 6.5.4.2 Saudi Arabia
      • 6.5.4.2.1 Key market trends, growth factors and opportunities
      • 6.5.4.2.2 Market size and forecast, by Treatment
      • 6.5.4.2.3 Market size and forecast, by End User
      • 6.5.4.3 South Africa
      • 6.5.4.3.1 Key market trends, growth factors and opportunities
      • 6.5.4.3.2 Market size and forecast, by Treatment
      • 6.5.4.3.3 Market size and forecast, by End User
      • 6.5.4.4 Rest of LAMEA
      • 6.5.4.4.1 Key market trends, growth factors and opportunities
      • 6.5.4.4.2 Market size and forecast, by Treatment
      • 6.5.4.4.3 Market size and forecast, by End User

CHAPTER 7: COMPANY LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Key developments

CHAPTER 8: COMPANY PROFILES

  • 8.1 Hoppers Physio
    • 8.1.1 Company overview
    • 8.1.2 Company snapshot
    • 8.1.3 Operating business segments
    • 8.1.4 Product portfolio
    • 8.1.5 Business performance
    • 8.1.6 Key strategic moves and developments
  • 8.2 Jeevam Therapy
    • 8.2.1 Company overview
    • 8.2.2 Company snapshot
    • 8.2.3 Operating business segments
    • 8.2.4 Product portfolio
    • 8.2.5 Business performance
    • 8.2.6 Key strategic moves and developments
  • 8.3 Physiocomestoyou
    • 8.3.1 Company overview
    • 8.3.2 Company snapshot
    • 8.3.3 Operating business segments
    • 8.3.4 Product portfolio
    • 8.3.5 Business performance
    • 8.3.6 Key strategic moves and developments
  • 8.4 EURO-THERAPIES
    • 8.4.1 Company overview
    • 8.4.2 Company snapshot
    • 8.4.3 Operating business segments
    • 8.4.4 Product portfolio
    • 8.4.5 Business performance
    • 8.4.6 Key strategic moves and developments
  • 8.5 Institute for Child Development
    • 8.5.1 Company overview
    • 8.5.2 Company snapshot
    • 8.5.3 Operating business segments
    • 8.5.4 Product portfolio
    • 8.5.5 Business performance
    • 8.5.6 Key strategic moves and developments
  • 8.6 Blossoms Physiotherapy
    • 8.6.1 Company overview
    • 8.6.2 Company snapshot
    • 8.6.3 Operating business segments
    • 8.6.4 Product portfolio
    • 8.6.5 Business performance
    • 8.6.6 Key strategic moves and developments
  • 8.7 Pediatric Advanced Therapy
    • 8.7.1 Company overview
    • 8.7.2 Company snapshot
    • 8.7.3 Operating business segments
    • 8.7.4 Product portfolio
    • 8.7.5 Business performance
    • 8.7.6 Key strategic moves and developments
  • 8.8 Chatham Speech and Myo
    • 8.8.1 Company overview
    • 8.8.2 Company snapshot
    • 8.8.3 Operating business segments
    • 8.8.4 Product portfolio
    • 8.8.5 Business performance
    • 8.8.6 Key strategic moves and developments
  • 8.9 Movement Masters Physical Therapy
    • 8.9.1 Company overview
    • 8.9.2 Company snapshot
    • 8.9.3 Operating business segments
    • 8.9.4 Product portfolio
    • 8.9.5 Business performance
    • 8.9.6 Key strategic moves and developments
  • 8.10 Rio Children's Hospital
    • 8.10.1 Company overview
    • 8.10.2 Company snapshot
    • 8.10.3 Operating business segments
    • 8.10.4 Product portfolio
    • 8.10.5 Business performance
    • 8.10.6 Key strategic moves and developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제